US stock · US markets · public data

DXCM

Dexcom Inc · Healthcare

Reference price$83.87Updated according to the public source
P/E33.28
P/B12.07
ROE38.49%
DY 12M0.00%
Net margin—
Net debt/equity—
Market capUS$ 31.6 B
Volume (shares)1,685,316
SectorHealthcare
Overview

About DXCM

Demonstrações públicas consolidadas + SEC Company Facts

Dexcom Inc (DXCM) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data

The source returned no recent distributions for this asset.

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$3,622,300,000.00$4,033,000,000.00$4,662,000,000.00—
Gross Profit$2,288,900,000.00$2,438,200,000.00$2,801,900,000.00—
Operating Income$597,700,000.00$600,000,000.00$911,800,000.00—
Net Income$541,500,000.00$576,200,000.00$836,300,000.00—
EPS Diluted$1.30 / share$1.42 / share$2.09 / share—

Balance sheet

Account2023202420252026
Total Assets$6,264,500,000.00$6,484,500,000.00$6,339,900,000.00—
Total Liabilities$4,195,900,000.00$4,381,900,000.00$3,593,900,000.00—
Total Equity$2,068,600,000.00$2,102,600,000.00$2,746,000,000.00—
Long-term Debt————
Shares Outstanding386,413,690 shares385,515,421 shares390,772,018 shares384,864,842 shares
Cash & Investments————

Cash flow

Account2023202420252026
Operating Cash Flow$748,500,000.00$989,500,000.00$1,440,700,000.00—
Capital Expenditures$236,600,000.00$358,800,000.00$363,500,000.00—
Free Cash Flow$511,900,000.00$630,700,000.00$1,077,200,000.00—
FAQ

Frequently asked questions

What is the price of DXCM?

The reference price available for DXCM is $83.87.

What is the P/E of DXCM?

The P/E ratio of DXCM is 33.28. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of DXCM?

The P/B of DXCM is 12.07. This compares price with reported book value per share.

What is the ROE of DXCM?

The ROE (Return on Equity) of DXCM is 38.49%. This relates the reported net result to shareholders' equity.

What is the dividend yield of DXCM?

The dividend yield of DXCM is 0.00%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of DXCM?

The market capitalization of DXCM is US$ 31.6 B.

What sector is DXCM in?

DXCM operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.